wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33438494-E41160EE-22FA-4001-BA0B-90D7C060DC5D
Q33438494-E41160EE-22FA-4001-BA0B-90D7C060DC5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438494-E41160EE-22FA-4001-BA0B-90D7C060DC5D
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
P2860
Q33438494-E41160EE-22FA-4001-BA0B-90D7C060DC5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438494-E41160EE-22FA-4001-BA0B-90D7C060DC5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee559c066d2ad7dbcd11c45cefe5dbd4ec99178e
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies